3 drugs to watch in early 2022

OptumRx, the pharmacy benefit manager unit of UnitedHealth Group, shared three drugs to watch in the first quarter of 2022 in its latest "Drug Pipeline Insights Report."

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive